MicroRNA are small endogenous RNA that regulates gene-expression post-transcriptionally. MicroRNA are abundantly found in the mammalian types and target approximately 60% of the genes of the human and other mammals. MiRNA reverse transcription are crucial regulators of gene expression and promising candidates for biomarker development. A single miRNA can target hundreds of mRNAs and influence the expression of many genes. Further, miRNA reverse transcription involved in many allergies’ diseases including eosinophilic esophagitis, asthma and many others which is likely to increase the demand for MicroRNA Reverse Transcription. Current methodologies used for MicroRNA reverse transcription such as RNA-sequencing, microarrays and quantitative PCR.
Increasing prevalence of Cancer, neurological disorder and others are expected to drive the MicroRNA reverse transcription market. MicroRNA reverse transcriptase is found to be associated with immune system, cancer stem cell and androgen receptor expression properties in triple negative breast cancer. In addition, MicroRNA reverse transcriptase market is expected to rise exponentially due to further development in genomics technologies and computational approaches. Further, therapeutics demonstration in preclinical studies using these molecules is anticipated to increase the R&D investment in the coming years. Furthermore, there are various kits available such as the TaqMan, MicroRNA reverse transcriptase is specifically designed to generate specific cDNA, for the use with the TaqMan MicroRNA Assays is also expected to increase the growth of MicroRNA reverse transcriptase market.
Accurate delivery of these molecules to an intracellular site such as nucleus and cytosol and also limited research infrastructure in emerging market are expected to hinder the growth of MicroRNA reverse transcriptase market.
The global MicroRNA reverse transcription market is classified on the basis of components type, methods, application, end user and region.
Based on Components Types, MicroRNA Reverse Transcription Market is segmented into the following:
By Products Type:
By Services Type:
Based on Methods, MicroRNA Reverse Transcription Market is segmented into the following:
Based on Application, MicroRNA Reverse Transcription Market is segmented into the following:
Based on End User, MicroRNA Reverse Transcription Market is segmented into the following:
Global MicroRNA Reverse Transcription market is segmented on the basis of components type, methods, application, end user and region. On the basis of product type, consumables are expected to represent the leading share in the MicroRNA Reverse Transcription market. On the basis of methods, quantitative PCR is expected to increase the demand for MicroRNA Reverse Transcription which is used to diagnose diseases, match criminals’ crimes and identify bacteria. Furthermore, on the basis of application, shifting focus on pipeline research for infectious and cancer attributed to their high occurrence and failure rate of existing treatment processes can further propel growth followed by neurological and cardiovascular disorders. On the basis of end user, academic and research institutes are expected to enhance effectiveness of microRNA drug technology which is likely to witness maximum growth forecast period.
Geographically, the MicroRNA Reverse Transcription market is segmented into regions such as Latin America, Europe, North America, South Asia, East Asia Middle East & Africa and Oceania. North America is projected to emerge as prominent market in the MicroRNA Reverse Transcription market due to several factors such as increasing prevalence of chronic and acute disease, access to advanced technologies and rising demand for preventive medical care followed by Europe. Asia pacific is the expected to show lucrative growth due to increasing access to advanced technologies, geriatric population, increasing disposable incomes and also demand for advanced diagnostic procedure. However, unmet needs for MicroRNA Reverse Transcription is expected to drive the Middle East and Africa.
Some of the major key players competing in the MicroRNA Reverse Transcription market are Sigma Aldrich Corp., Thermo Fisher Scientific, Inc., Agilent Technologies, Illumina, Inc., Bio-Rad Laboratories Inc., System Biosciences LLC, HTG Molecular Diagnostics, Inc., GeneCopoeia, Inc. and New England Biolabs, Inc.
The report covers exhaustive analysis on:
Regional analysis includes